Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04301245
Other study ID # RETRO-ETP
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 28, 2020
Est. completion date April 10, 2020

Study information

Verified date May 2020
Source ADIR Association
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Pulmonary rehabilitation (PR) has proven its efficacy to improve dyspnea, health status, exercise tolerance and quality of life for patients with stable Chronic Obstructive Pulmonary Disease (COPD). Exercise training has previously been thoroughly studied but education has been less studied in PR. Furthermore, only few studies have investigated the added value of an educational program (EP) to exercise training on clinical and physical factors. Characterizing those patients who refuse EP is therefore a first step to better target them and potentially improve their adherence and outcome following PR.

The aim of this study was to determine the characteristics of the COPD patients referred to PR who refused EP compare to those who accepted and to identify the independent predictive factors of refusal. The investigators also sought to compare the change in clinical outcomes and number and length of hospitalization at six months following PR among those patients who accepted or not to participate in EP.


Recruitment information / eligibility

Status Completed
Enrollment 201
Est. completion date April 10, 2020
Est. primary completion date March 31, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Clinical diagnosis of COPD,

- >18 years old,

- Stable state of COPD.

Exclusion Criteria:

- Patients who have not been offered an educational program

- Patients who have already been offered an educational program during a pulmonary rehabilitation in the same center.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Educational program
The educational program (EP) was offered during the initial session of the pulmonary rehabilitation. According to the french law, patients were free to participate or not. The EP consisted of an educational diagnosis, educational workshops and an individual final assessment.

Locations

Country Name City State
France ADIR Association Bois-Guillaume

Sponsors (1)

Lead Sponsor Collaborator
ADIR Association

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Multiple logistic regression between the variables defined and the refusal of educational program The variables are described below in primary outcomes Baseline
Primary Gender Gender will be analysed in logistic regression. Baseline
Primary Age Age will be analysed in logistic regression. Baseline
Primary Height Height will be analysed in logistic regression. Baseline
Primary Weight Weight will be analysed in logistic regression. Baseline
Primary Body mass index Body mass index will be analysed in logistic regression. Baseline
Primary COPD stages COPD stages will be analysed in logistic regression. Baseline
Primary Forced Expiratory Volume in one second Forced Expiratory Volume in one second will be analysed in logistic regression. Baseline
Primary Forced Vital Capacity Forced Vital Capacity will be analysed in logistic regression. Baseline
Primary Ratio between Forced Expiratory Volume in one second and Forced Vital Capacity Ratio between Forced Expiratory Volume in one second and Forced Vital Capacity will be analysed in logistic regression. Baseline
Primary Total Lung Capacity Total Lung Capacity will be analysed in logistic regression. Baseline
Primary Residual Volume Residual Volume will be analysed in logistic regression. Baseline
Primary Diffusing capacity of the lungs for carbon monoxide divided by alveolar volume Diffusing capacity of the lungs for carbon monoxide divided by alveolar volume will be analysed in logistic regression. Baseline
Primary Comorbidities Comorbidities will be analysed in logistic regression. Baseline
Primary Tabacco status Tabacco status will be analysed in logistic regression. Baseline
Primary Tabacco consumption Tabacco consumption will be analysed in logistic regression. Baseline
Primary Prescription of oxygen Prescription of oxygen will be analysed in logistic regression. Baseline
Primary Prescription of non invasive ventilation Prescription of non invasive ventilation will be analysed in logistic regression. Baseline
Primary Arterial oxygen partial pressure Arterial oxygen partial pressure will be analysed in logistic regression. Baseline
Primary Arterial carbon dioxide partial pressure Arterial carbone dioxide partial pressure will be analysed in logistic regression. Baseline
Primary Location of the training sessions Location of the training sessions will be analysed in logistic regression. Baseline
Primary Ambulance transport Number of patients with an ambulance transport will be analysed in logistic regression. Baseline
Primary Distance between patient's home and center Distance between patient's home and center will be analysed in logistic regression. Baseline
Primary Dyspnea Dyspnea assessed by the modified Medical Research Council scale will be analysed in logistic regression. Baseline
Primary 6-Minute Stepper Test Number of steps during the 6-Minute Stepper Test will be analysed in logistic regression. Baseline
Primary 6-Minute Walk Test Distance during the 6-Minute Walk Test will be analysed in logistic regression. Baseline
Primary Maximal oxygen consumption Maximal oxygen consumption during cardiopulmonary exercise testing will be analysed in logistic regression. Baseline
Primary Maximal workload Maximal workload achieved during cardiopulmonary exercise testing will be analysed in logistic regression. Baseline
Primary Saint George's Respiratory Questionnaire Quality of life assessed by Saint George's Respiratory Questionnaire will be analysed in logistic regression. Baseline
Primary Employment Employment will be analysed in logistic regression. Baseline
Primary Educational level Educational level assessed by the international classification "Classification Internationale Type de l'Education" will be analysed in logistic regression. Baseline
Primary Cognitive impairment Cognitive impairment assessed by the Montreal Cognitive Assessment will be analysed in logistic regression. Baseline
Primary Anxiety and depression level Anxiety and depression level assessed by the Hospital Anxiety and Depression scale will be analysed in logistic regression. Baseline
Secondary 6-Minute Stepper Test Change in number of steps during the 6-Minute Stepper Test will be compared between groups. 2 months
Secondary 6-Minute Walk Test Change in distance during the 6-Minute Walk Test will be compared between groups. 2 months
Secondary Saint George's Respiratory Questionnaire Change in Saint George's Respiratory Questionnaire will be compared between groups. 2 months
Secondary Anxiety and depression level Anxiety and depression level assessed by the Hospital Anxiety and Depression scale will be analysed in logistic regression. 2 months
Secondary Cognitive impairment Change in cognitive impairment assessed by the Montreal Cognitive Assessment will be compared between groups. 2 months
Secondary Number of hospitalizations Number of hospitalizations will be compared between groups. 6 months
Secondary Number of hospitalized patients Number of hospitalized patients will be compared between groups. 6 months
Secondary Number of days of hospitalization Number of days of hospitalization will be compared between groups. 6 months
Secondary Attendance rate at educational sessions Attendance rate at education sessions will be analysed 2 months
See also
  Status Clinical Trial Phase
Completed NCT05102305 - A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
Completed NCT01867762 - An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Phase 2
Recruiting NCT05562037 - Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA N/A
Terminated NCT04921332 - Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD N/A
Completed NCT03089515 - Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust N/A
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT05552833 - Pulmonary Adaptive Responses to HIIT in COPD N/A
Recruiting NCT05835492 - A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
Recruiting NCT05631132 - May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases? N/A
Completed NCT03244137 - Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
Not yet recruiting NCT03282526 - Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease N/A
Completed NCT02546700 - A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 2
Withdrawn NCT04446637 - Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD Phase 3
Completed NCT04535986 - A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD Phase 3
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Completed NCT03295474 - Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
Completed NCT03256695 - Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Withdrawn NCT04042168 - Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT03414541 - Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease Phase 2
Completed NCT02552160 - DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy